お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
640305

糖尿病アッセイ:医療機器のパイプライン評価

Diabetes Assays - Medical Devices Pipeline Assessment, 2020

出版日: | 発行: GlobalData | ページ情報: 英文 75 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.93円
糖尿病アッセイ:医療機器のパイプライン評価
出版日: 2020年12月01日
発行: GlobalData
ページ情報: 英文 75 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の糖尿病アッセイ (糖尿病検定) の関連製品市場における、主要なパイプライン製品とその治験の進行状況について調査すると共に、製品の機能・特性の比較分析 (治験の進行段階別) や、主要企業・組織のプロファイルおよび代表的製品、昨今の市場動静 (業績報告・資本取引動向など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 糖尿病アッセイの概要

第3章 治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:分野別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別

第4章 糖尿病アッセイ:治験中のパイプライン製品、企業別

  • 糖尿病アッセイの企業:治験段階別のパイプライン製品
  • 糖尿病アッセイ:治験段階別のパイプライン製品

第5章 糖尿病アッセイ市場:企業・製品の概要

  • Abcodia Ltd
    • パイプライン製品の情報、現在進行中の治験の概要
  • Adaptive Biotechnologies Corp
  • Alfa Wassermann Inc
  • AmideBio LLC
  • Aura Biotechnologies Pvt Ltd
  • Beckman Coulter Inc
  • Biocrates Life Sciences AG
  • Caprion Biosciences Inc
  • DaekiTech
  • Drexel University
  • ELITechGroup Inc
  • Enable Biosciences Inc
  • FibroStatin SL
  • Fujirebio Diagnostics Inc
  • Genalyte Inc
  • Genesis Detection Systems, Inc.
  • Helmholtz Centre for Infection Research
  • Hemex Health Inc
  • ImmusanT Inc
  • IntraMed Diagnostics, LLC
  • Janssen Diagnostics LLC
  • Johns Hopkins University
  • Mellitus LLC
  • Numares AG
  • Ortho-Clinical Diagnostics Inc
  • Peri Rx Inc
  • PortaScience Inc
  • Protagen AG
  • Queen Mary University of London
  • QuickCheck Health Inc
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Singulex Inc
  • SomaLogic Inc
  • The Forsyth Institute
  • University of Canterbury
  • University of Colorado
  • University of Florida
  • University of Oxford
  • University of South Florida
  • Xhale Inc
  • Yaathum Biotech Pvt Ltd

第6章 糖尿病アッセイ市場:昨今の動向 (全10件)

第7章 付録

図表

List of Tables

List of Tables

  • Table 1: Diabetes Assays - Pipeline Products by Stage of Development
  • Table 2: Diabetes Assays - Pipeline Products by Segment
  • Table 3: Diabetes Assays - Pipeline Products by Territory
  • Table 4: Diabetes Assays - Pipeline Products by Regulatory Path
  • Table 5: Diabetes Assays - Pipeline Products by Estimated Approval Date
  • Table 6: Diabetes Assays Companies - Pipeline Products by Stage of Development
  • Table 7: Diabetes Assays - Pipeline Products by Stage of Development
  • Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Molecular Biomarker - Diabetes - Product Status
  • Table 10: Molecular Biomarker - Diabetes - Product Description
  • Table 11: Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Pre - Symptomatic Biomarker - Type 1 Diabetes - Product Status
  • Table 13: Pre - Symptomatic Biomarker - Type 1 Diabetes - Product Description
  • Table 14: Adipomics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Diagnostic Test - Gestational Pre-Diabetes - Product Status
  • Table 16: Diagnostic Test - Gestational Pre-Diabetes - Product Description
  • Table 17: ADiTx Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: AditxtScore Assay - Type I Diabetes - Product Status
  • Table 19: AditxtScore Assay - Type I Diabetes - Product Description
  • Table 20: Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: ACE Alera Clinical Chemistry System - Direct A1c Assay - Product Status
  • Table 22: ACE Alera Clinical Chemistry System - Direct A1c Assay - Product Description
  • Table 23: AmideBio LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Diagnostic Test - T1 Diabetes - Product Status
  • Table 25: Diagnostic Test - T1 Diabetes - Product Description
  • Table 26: Aura Biotechnologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: AURA Quant Glargine ELISA Kit - Product Status
  • Table 28: AURA Quant Glargine ELISA Kit - Product Description
  • Table 29: AURA Quant Human C-peptide Kit - Product Status
  • Table 30: AURA Quant Human C-peptide Kit - Product Description
  • Table 31: AURA Quant Human Insulin ELISA Kit - Product Status
  • Table 32: AURA Quant Human Insulin ELISA Kit - Product Description
  • Table 33: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: AU480 Clinical System - Next Generation HbA1c Assay - Product Status
  • Table 35: AU480 Clinical System - Next Generation HbA1c Assay - Product Description
  • Table 36: AU5810 Clinical System - Next-generation HbA1c Assay - Product Status
  • Table 37: AU5810 Clinical System - Next-generation HbA1c Assay - Product Description
  • Table 38: AU5820 Clinical System - Next-generation HbA1c Assay - Product Status
  • Table 39: AU5820 Clinical System - Next-generation HbA1c Assay - Product Description
  • Table 40: AU5830 Clinical System - Next-generation HbA1c Assay - Product Status
  • Table 41: AU5830 Clinical System - Next-generation HbA1c Assay - Product Description
  • Table 42: AU5840 Clinical System - Next-generation HbA1c Assay - Product Status
  • Table 43: AU5840 Clinical System - Next-generation HbA1c Assay - Product Description
  • Table 44: AU680 Clinical System - Next-generation HbA1c Assay - Product Status
  • Table 45: AU680 Clinical System - Next-generation HbA1c Assay - Product Description
  • Table 46: Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: Diagnostic Assay - Type 2 Diabetes - Product Status
  • Table 48: Diagnostic Assay - Type 2 Diabetes - Product Description
  • Table 49: BioDesign Institute at Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Biomarker Test - Type 1 Diabetes - Product Status

List of Figures

List of Figures

  • Figure 1: Diabetes Assays - Pipeline Products by Stage of Development
  • Figure 2: Diabetes Assays - Pipeline Products by Segment
  • Figure 3: Diabetes Assays - Pipeline Products by Territory
  • Figure 4: Diabetes Assays - Pipeline Products by Regulatory Path
  • Figure 5: Diabetes Assays - Pipeline Products by Estimated Approval Date
目次
Product Code: GDME1092EPD

GlobalData's Medical Devices sector report, "Diabetes Assays - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Diabetes Assays pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Diabetes assay are used to measure glucose levels in patient's sample. This segment comprises of C-peptide assays, glycated hemoglobin (HbA1c) Assays, Insulin assays and other diabetes assays.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Diabetes Assays under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Diabetes Assays and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Diabetes Assays under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Diabetes Assays Overview

3 Products under Development

  • 3.1 Diabetes Assays - Pipeline Products by Stage of Development
  • 3.2 Diabetes Assays - Pipeline Products by Segment
  • 3.3 Diabetes Assays - Pipeline Products by Territory
  • 3.4 Diabetes Assays - Pipeline Products by Regulatory Path
  • 3.5 Diabetes Assays - Pipeline Products by Estimated Approval Date

4 Diabetes Assays - Pipeline Products under Development by Companies

  • 4.1 Diabetes Assays Companies - Pipeline Products by Stage of Development
  • 4.2 Diabetes Assays - Pipeline Products by Stage of Development

5 Diabetes Assays Companies and Product Overview

  • 5.1 Abcodia Ltd Company Overview
    • 5.1.1 Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Adaptive Biotechnologies Corp Company Overview
    • 5.2.1 Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Adipomics Inc Company Overview
    • 5.3.1 Adipomics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 ADiTx Therapeutics Inc Company Overview
    • 5.4.1 ADiTx Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Alfa Wassermann Inc Company Overview
    • 5.5.1 Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 AmideBio LLC Company Overview
    • 5.6.1 AmideBio LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Aura Biotechnologies Pvt Ltd Company Overview
    • 5.7.1 Aura Biotechnologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Beckman Coulter Inc Company Overview
    • 5.8.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Biocrates Life Sciences AG Company Overview
    • 5.9.1 Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 BioDesign Institute at Arizona State University Company Overview
    • 5.10.1 BioDesign Institute at Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Caprion Biosciences Inc Company Overview
    • 5.11.1 Caprion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Confer Health Inc Company Overview
    • 5.12.1 Confer Health Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 DaekiTech Company Overview
    • 5.13.1 DaekiTech Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Drexel University Company Overview
    • 5.14.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 ELITechGroup Inc Company Overview
    • 5.15.1 ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Enable Biosciences Inc Company Overview
    • 5.16.1 Enable Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 FibroStatin SL Company Overview
    • 5.17.1 FibroStatin SL Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Fujirebio Diagnostics Inc Company Overview
    • 5.18.1 Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 Genesis Detection Systems, Inc. Company Overview
    • 5.19.1 Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 Helmholtz Centre for Infection Research Company Overview
    • 5.20.1 Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Hemex Health Inc Company Overview
    • 5.21.1 Hemex Health Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 IntraMed Diagnostics, LLC Company Overview
    • 5.22.1 IntraMed Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 Janssen Diagnostics LLC Company Overview
    • 5.23.1 Janssen Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 Johns Hopkins University Company Overview
    • 5.24.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 L2 Diagnostics LLC Company Overview
    • 5.25.1 L2 Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 Mellitus LLC Company Overview
    • 5.26.1 Mellitus LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 Numares AG Company Overview
    • 5.27.1 Numares AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 Ortho-Clinical Diagnostics Inc Company Overview
    • 5.28.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 Peri Rx Inc Company Overview
    • 5.29.1 Peri Rx Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 PortaScience Inc Company Overview
    • 5.30.1 PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 Protagen AG Company Overview
    • 5.31.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 Queen Mary University of London Company Overview
    • 5.32.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33 QuickCheck Health Inc Company Overview
    • 5.33.1 QuickCheck Health Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34 Sebia SA Company Overview
    • 5.34.1 Sebia SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35 Singulex Inc Company Overview
    • 5.35.1 Singulex Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36 SomaLogic Inc Company Overview
    • 5.36.1 SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37 The Forsyth Institute Company Overview
    • 5.37.1 The Forsyth Institute Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38 University of Canterbury Company Overview
    • 5.38.1 University of Canterbury Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39 University of Colorado Company Overview
    • 5.39.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40 University of Florida Company Overview
    • 5.40.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41 University of Oxford Company Overview
    • 5.41.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42 University of South Florida Company Overview
    • 5.42.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43 University of Strathclyde Company Overview
    • 5.43.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44 Xhale Inc Company Overview
    • 5.44.1 Xhale Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45 Yaathum Biotech Pvt Ltd Company Overview
    • 5.45.1 Yaathum Biotech Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Appendix

  • 6.1 Methodology
  • 6.2 About GlobalData
  • 6.3 Contact Us
  • 6.4 Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.